Document Preview Unavailable

Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease

Layton, J. Bradley; Ziemiecki, Ryan; Johannes, Catherine B; Pladevall-Vila, Manel; Khan, Anam M; et al.  Diabetes Therapy Vol. 16, Iss. 8,  (Aug 2025): 1597-1614.

You might have access to this document